About us

We are a group of independent consultants who first started at established PR agencies. If you would try to summarise our overall experience, the final result would sum up to approximately 30 years of activity. We still like to think outside the box, however, even though we plan strategies keeping our feet firmly on the ground. We remain close to our clients because we engage only in projects that we believe in. We have our passions, and marketing and PR communication are at the top of our list.

Consultants

Agnieszka Krysztofowicz

For a dozen years or so, Agnieszka has been working on 360 Degrees Communication strategies; she has provided consultancy for both small local companies, local governments, and large international corporations. Agnieszka promotes out-of-the-box thinking: she values lateral approach supported by reasoned situational analysis. Agnieszka collaborated with such companies and institutions as Agros Nova, Colgate-Palmolive, Johnson&Johnson, European Commission, PKP Energetyka, and Warsaw City Hall. Agnieszka is a journalism graduate of the University of Warsaw.

Radosław Pancewicz

Radosław has been planning and implementing comprehensive PR and marketing campaigns for 8 years now. Radosław specializes in developing brand images and in corporate and educational projects. His portfolio includes collaboration with such companies as Adidas, Diageo, Janssen, Lanxess, Panasonic, and Pfizer. Radosław graduated from the Faculty of Political Science at Adam Mickiewicz University in Poznań; he is a member of Public Relations Consultants Association in London.

Maria Konieczna

Maria has worked in PR since 2008, and specializes in strategic consulting and comprehensive marketing and communication service for vulnerable segments. Maria implemented online and offline campaigns for a number of clients, including Adamed, Bayer, IBSA, Ferring, GSK, PZU, and PGE. Maria holds diplomas in the fields of economy, coaching and marketing strategies development. Moreover, she has been awarded distinctions for projects devoted to CSR issues.

Only long-term and multidimensional endeavours can create or change a company or a product image. Where to start? From well-knit and comprehensive communication strategy that will guide and outline all subsequent projects.

You can build up your company's reputation but it would be much better to manage it skilfully. Gaining support of the media, opinion leaders and institutions important for your business is a good start for your route to success.

The fish stinks from the head down, just like a company. Only well-informed internal client is able to understand and support all processes shaping a business and its environment.

A brand is not just a product, as it also comprises values that stand behind it. How to convince a consumer to share these values? There are as many methods as products on the market.

Business responsibility is more than a trend: it is an obligation. Well-tailored CSR programme will benefit both a company and its environment.

Education can change the market. A well-informed client is a better client, and the expert position is a good starting point for becoming a game leader.

It is worth including the new media presence within a broader communication strategy frame. Each vote is important, and interaction with a consumer or partner is a kind of opportunity that was not available several years ago.

The best crisis is the one that does not exist. Crisis communication cannot be reduced to fire-fighting, as it is mainly about preventing fire.

Companies do not decide to create a PR department for different causes. Regardless of the reason, however, we are ready to build such a division for you and manage it comprehensively.

Services


Interesting Facts I Bet You Never Knew About Xarelto Lawsuit

Interesting Facts I Bet You Never Knew About Xarelto Lawsuit

recalled medicationsOur attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical businesses, like the makers of Xarelto, possess a duty to make sure that their drugs are reasonably protected for use - and failure to complete so may be grounds for compensation. Our lawyers are working tough to acquire these hurt by the drug the compensation they are entitled to.

While bleeding can be a xareltonews.netlify.com widespread complication associated with anticoagulants, it has been alleged that Xarelto is a lot more unsafe than standard blood thinners because no antidote exists to reverse its blood-thinning effects. This indicates that, inside the occasion of an emergency, patients might be at risk for irreversible bleeding problems, which includes life-threatening internal and gastrointestinal hemorrhaging.

Should you or possibly a loved 1 suffered a serious bleeding occasion soon after taking Xarelto, you might have legal recourse. For much more information, get in touch with us nowadays to possess your case reviewed, free of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for previous and future health-related bills, lost wages, discomfort and suffering and, in cases of death, funeral expenses. Moreover, they're in search of punitive damages, which are typically awarded to punish the defendant and deter other firms from acting similarly.
Why Are Lawsuits Being Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding inside the event of an emergency. Plaintiffs inside the lawsuits allege critical and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

recalled medicationsThe manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a secure anticoagulant option.
Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.

Visit this page for a lot more details on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.

Contact us

+48 664 922 145

Interesting Facts I Bet You Never Knew About Xarelto Lawsuit

Interesting Facts I Bet You Never Knew About Xarelto Lawsuit

recalled medicationsOur attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical businesses, like the makers of Xarelto, possess a duty to make sure that their drugs are reasonably protected for use - and failure to complete so may be grounds for compensation. Our lawyers are working tough to acquire these hurt by the drug the compensation they are entitled to.

While bleeding can be a xareltonews.netlify.com widespread complication associated with anticoagulants, it has been alleged that Xarelto is a lot more unsafe than standard blood thinners because no antidote exists to reverse its blood-thinning effects. This indicates that, inside the occasion of an emergency, patients might be at risk for irreversible bleeding problems, which includes life-threatening internal and gastrointestinal hemorrhaging.

Should you or possibly a loved 1 suffered a serious bleeding occasion soon after taking Xarelto, you might have legal recourse. For much more information, get in touch with us nowadays to possess your case reviewed, free of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for previous and future health-related bills, lost wages, discomfort and suffering and, in cases of death, funeral expenses. Moreover, they're in search of punitive damages, which are typically awarded to punish the defendant and deter other firms from acting similarly.
Why Are Lawsuits Being Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding inside the event of an emergency. Plaintiffs inside the lawsuits allege critical and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

recalled medicationsThe manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a secure anticoagulant option.
Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.

Visit this page for a lot more details on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.